Timektomija neposredno po završetku miastenične krize

  • Vesna Martić Military Medical Academy, Clinic for Neurology, Belgrade, Serbia
  • Nebojša Marić University of Defence, Faculty of Medicine of the Military Medical Academy, Belgrade, Serbia
  • Dragan Djordjević University of Defence, Faculty of Medicine of the Military Medical Academy, Belgrade, Serbia
Ključne reči: miastenia gravis, dijagnoza, timektomija, kritična stanja, lečenje, ishod

Sažetak


Uvod. Miastenična kriza dovodi do brze progresije miastenične slabosti koja je udružena sa respiratornom i bulbarnom disfunkcijom. Kako nije strogo prihvaćen nijedan standard u lečenju svih bolesnika u krizi, u radu smo prikazali naša iskustva u lečenju jednog takvog bolesnika. Prikaz bolesnika. U radu je prikazan bolesnik, star 22 godine, sa klinički, farmakološki i imunološki dijagnostikovanom seropozitivnom generalizovanom miastenijom gravis nestabilnog toka. Tokom prvih 6 meseci bolesti registrovana su tri pogoršanja, dok se poslednje razvilo u miasteničnu krizu. Bolesnik je intubiran, ranijа antiholinesterazna i imunosupresivna terapija su korigovane, a on je, tokom krize, lečen izmenama plazme i humanim imunoglobulinima. Posle timektomije, izvršene 3 sedmice posle ekstubacije, bolesnik je bio stabilan. Zaključak. Napredak u lečenju miastenične krize tokom poslednjih decenija dramatično je poboljšao prognozu miastenične krize. Timektomija je korisna u prevenciji ponavljanih miasteničnih kriza.

Reference

Sanders DB, Wolfe GI, Benatar M, Evoli A, Gilhus NE, Illa I, et al. International consensus guidance for management of myas-thenia gravis: Executive summary. Neurology 2016; 87(4): 419–25.

Juel VC. Myasthenia gravis: management of myasthenic crisis and perioperative care. Semin Neurol 2004; 24(1): 75–81.

Liu Z, Yao S, Zhou Q, Deng Z, Zou J, Feng H, et al. Predictors of extubation outcomes following myasthenic crisis. J Int Med Res 2016; 44(6): 1524‒33.

Chaudhuri A, Behan PO. Myasthenic crisis. QJM 2009; 102(2): 97–107.

Stetefeld HR, Schroeter M. Myasthenic Crisis. Fortschr Neurol Psychiatr 2018; 86(5): 301‒7.

Lizarraga AA, Lizarraga KJ, Benatar M. Getting Rid of Weak-ness in the ICU: An Updated Approach to the Acute Man-agement of Myasthenia Gravis and Guillain-Barré Syndrome. Semin Neurol 2016; 36(6): 615‒24.

Roper J, Fleming ME, Long B, Koyfman A. Myasthenia Gravis and Crisis: Evaluation and Management in the Emergency Department. J Emerg Med 2017; 53(6): 843‒53.

Jani-Acsadi A, Lisak RP. Myasthenic crisis: guidelines for pre-vention and treatment. J Neurol Sci 2007; 261(1‒2): 127‒33.

Godoy DA, Mello LJ, Masotti L, Di Napoli M. The myasthenic patient in crisis: an update of the management in Neurointen-sive Care Unit. Arq Neuropsiquiatr 2013; 71(9A): 627–39.

Liu N, Liu Q, Wu X, Liu K, Vadis Q. Predictors of outcome of myasthenic crisis. Neurol Sci 2015; 36(5): 801–2.

Onuki T, Ueda S Otsu S, Yanagihara T, Kawakami N, Yamaoka M, et al. Thymectomy during Myasthenic Crisis under Artifi-cial Respiration. Ann Thorac Cardiovasc Surg 2019; 25(4): 215‒8.

Objavljeno
2021/08/24
Rubrika
Prikaz bolesnika